Pulse Biosciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.75M, a 359.47% increase year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $400.00K, a 7.24% increase year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.71M, a 258.82% increase year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $12.00K, a 7.69% decline year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $2.50M, a 187.03% increase from fiscal 2024.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $871.00K, a 25.62% decline from fiscal 2023.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.17M.
- Pulse Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $616.00K, a 30.55% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $1.75M 10-Q · filed 2026-08-06 | $3.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.50M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.71M 10-Q · filed 2025-11-05 | $2.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $12.00K 10-Q · filed 2026-08-06 | $1.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $380.00K 10-Q · filed 2026-08-06 | $1.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $871.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $476.00K 10-Q · filed 2025-11-05 | $1.30M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $13.00K 10-Q · filed 2025-08-12 | $1.14M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-08 | $1.18M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M 10-K · filed 2025-03-31 |
| 2023-09-30 | $309.00K 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $58.00K 10-Q · filed 2024-08-19 | |
| 2021-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $616.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.05M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $59.00K 10-Q · filed 2022-08-10 | $1.39M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $449.00K 10-Q · filed 2022-05-11 | $1.33M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $887.00K 10-K · filed 2023-03-31 |
| 2020-09-30 | $340.00K 10-Q · filed 2021-11-15 | $349.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $9.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $9.00K 10-Q · filed 2021-05-10 | $9.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $272.00K 10-K · filed 2022-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $347.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $605.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $272.00K 10-Q · filed 2020-05-11 | $657.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $498.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $258.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $52.00K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $112.00K 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $489.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |